ARTICLE | Financial News
Fate Therapeutics amends IPO
September 9, 2013 7:00 AM UTC
Fate Therapeutics Inc., San Diego, Calif. Business: Gene/Cell therapy, Cancer, Musculoskeletal Date announced: 9/3/13 Type: IPO To be raised: Up to $73.6 million Shares: 4 million Price: $14-$16 Under...